secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2024-06-17T23:59:59+00:00
Accession:  0001493152-24-024110
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve all proposals at 2024 annual meeting
---------------------------------------------------------

- Five directors elected: Keyser, Sharma, Chandru, Maccecchini, Silberstein; each received ~3.04M votes for, ~22K withheld.
- Amendment to 2018 Equity Incentive Plan approved to increase share pool by 125,000 shares; 2.89M for, 128K against.
- Ratification of EisnerAmper LLP as independent auditor for FY2024 passed with 7.17M votes for, 40K against.
- Broker non-votes of 4.23M on director election and equity plan; no broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224024110/0001493152-24-024110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315224024110/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer